Clinical Trial Update: Histiocytic Disorder Follow-up Study

View source ↗

Summary

A University of Alabama at Birmingham-sponsored clinical trial update indicates recruiting for a histiocytic disorder follow-up study, including Langerhans cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erdheim-chester Disease
• Histiocytosis
• Langerhans Cell Histiocytosis
• Malignant Histiocytoses
• Rosai-dorfman Disease
• Xanthogranuloma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Histiocytosis, Langerhans Cell Histiocytosis | Status: RECRUITING